ResMed Corp (RMD): Debts to Book Capitalization

Corporate company logo of ResMed Corp (RMD)

Risks of electronic supply chain disruptions are limiting the scaling potential of cloud monitoring and consumables sales. The total debt-to-equity ratio on the GURU.Markets chart reflects this trend, where 0.13 represents the latest metric reading. Stable demand for apnea therapy equipment in the US, Australia, and Singapore supports the overall financial resilience of ResMed Inc. (RMD).

ResMed Inc. - RMD Debts to Book Capitalization (period 07/04/2022 - 10/27/2026)

Summary analytical data breakdowns for ResMed Inc (RMD)

- price and consensus price forecast:
Stock Price ResMed Inc.|RMD - Consensus Target
- market capitalization data:
Market Capitalization ResMed Corporation|RMD - Company Buyout Price
- book capitalization data:
Book Value per Share ResMed|RMD - Book Capitalization|Market Value to Book Value Ratio resmed.com|RMD - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Capital ResMed Inc.|RMD - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio ResMed Corp|RMD - Company Aggregate Indebtedness|Debts to Book Capitalization ResMed Corporation
Fundamental company analysis:ResMed Inc. - RMD
Brand item of ResMed Corporation

This indicator measures the degree of financial autonomy by comparing total credit obligations against the company's equity. Analyzing the ratio of debt to the book capitalization of ResMed Inc. (RMD) allows for an assessment of default risk and leverage management efficiency, which for ResMed Inc. (RMD) is supported by a strategy of maintaining proprietary high-tech capacities while partially outsourcing simple components to optimize costs.

Competitors of ResMed Inc.

Boston Scientific - Debts to Book Capitalization|Debt to Book Value edwards.com EW|Debts to Book Capitalization PODD (Insulet)|ZBH - Debts to Net Assets|COO: Debts to Book Capitalization|ALGN (Align Corp) - Debts to Book Capitalization|Debt to Book Capitalization Ratio Globus Medical, Inc.|Debt to Book Capitalization Ratio TransMedics Corp|ATEC (Alphatec) - Debts to Book Capitalization|Debts to Net Assets CryoLife AORT|DJO Global (ENOV) - Debt to Book Value|Debts to Book Capitalization Ratio Integra LifeSciences Inc. IART|ESTA (Establishment Labs) - Debts to Book Capitalization|BBNX - Debts to Book Value|Debts to Book Capitalization IRADIMED|Debt to Book Value Ratio Embecta Corp|TNDM - Debt to Book Value|Debt to Net Assets Ratio AXGN|Debt to Book Capitalization Ratio SIBN (SI-BONE, Inc.)|Debt to Book Value orthofix.com (OFIX)|BVS: Debts to Book Capitalization|Debts to Book Value OrthoPediatrics Corp KIDS|Treace Medical (TMCI) - Debts to Book Capitalization|SRTA - Debt to Book Value Ratio|Carlsmed Inc - Debts to Book Capitalization|rxsight.com (RXST) - Debts to Net Assets|Debts to Book Capitalization CLPT|Debt to Book Value Stereotaxis Inc|Debts to Book Capitalization STIM|Debts to Book Capitalization SGHT (Sight Sciences Inc)|Debt to Book Capitalization Ratio Orchestra BioMed, Inc. OBIO|ANIK - Debt to Book Capitalization Ratio|Debt to Book Value InspireMD (NSPR)|ZJYL - Debt to Net Assets Ratio|Debts to Book Capitalization VANI|XTNT (Xtant Medical) - Debts to Book Value|NeuroOne Medical Technologies - Debt to Book Capitalization Ratio|Debt to Net Assets Modular Med (MODD)|Debt to Book Value MYO|Debts to Book Capitalization Envoy Medical Inc. (COCH)|Debts to Book Capitalization VVOS|enVVeno Corp - Debts to Net Assets|Debt to Book Capitalization Ratio SINTX Technologies|TNON: Debts to Book Capitalization Ratio|LFWD (Lifeward) - Debt to Book Capitalization Ratio|Autonomix Medical (AMIX) - Debt to Book Value|Debts to Book Capitalization IVF (INVO Bioscience, Inc.)|Debts to Book Value BBLG|Debt to Book Capitalization Ratio Axonics, Inc. AXNX|Debt to Book Value Ratio biolase.com BIOL|Debt to Book Value Dynatronics (DYNT)|Paragon 28 Inc. - Debt to Book Capital|Debt to Book Capitalization Ratio INVO Bio (INVO)